Skip to main content

Table 1 Characteristics of breast cancer cases and controls, matched on age and menopausal status

From: Quantitative background parenchymal uptake on molecular breast imaging and breast cancer risk: a case-control study

Characteristic

Breast cancer cases (n = 62)

Controls (n = 177)

P

Age at MBI (years)a

60.3 ± 10.6 (38–88)

60.2 ± 10.4 (38–86)

NA

Menopausal status

  

NA

 Premenopausal

13 (21)

38 (22)

 

 Postmenopausal

49 (79)

138 (78)

Body mass index (kg/m2)a

27.7 ± 6.4 (18.8–55.5)

26.2 ± 4.7 (18.6–44.3)

0.06

Postmenopausal systemic hormone therapyb

  

0.57

 Current use at MBI

13 (27)

44 (31)

 

 No current use at MBI

36 (73)

97 (69)

 

BI-RADS density

  

0.81

 Almost entirely fat

1 (2)

3 (2)

 

 Scattered fibroglandular densities

10 (16)

34 (19)

 Heterogeneously dense

44 (71)

113 (64)

 Extremely dense

7 (11)

26 (15)

Percent densitya

24.8 ± 8.3 (3.5–48.0)

24.6 ± 10.2 (1.8–53.8)

0.93

Tumor invasiveness

 Invasive

45 (73)

NA

 

 DCIS

17 (27)

NA

Gail model 5-year riska

2.7 ± 1.5 (0.6–7.2)

2.4 ± 1.5 (0.5–9.5)

0.23

BCSC model 5-year riska

2.6 ± 1.2 (0.7–5.4)

2.3 ± 1.5 (0.4–13.2)

0.29

Family history of breast cancer

  

0.45

 One or more first-degree relatives

33 (53)

86 (48)

 

 No first-degree relatives

29 (47)

93 (52)

Personal history of biopsy showing atypia or LCIS

  

0.07

 Yes

6 (10)

6 (3)

 

 No

56 (90)

173 (97)

  1. Unless otherwise noted, data are number of patients and data in parentheses are percentages
  2. aData are mean ± standard deviation; data in parentheses are the range
  3. bData are among postmenopausal women only (49 breast cancer cases; 138 controls)
  4. BCSC, Breast Cancer Surveillance Consortium; BI-RADS, Breast Imaging-Reporting and Data System; DCIS, ductal carcinoma in situ; LCIS, lobular carcinoma in situ; MBI, molecular breast imaging; NA, not available